Yannoutsos, Alexandra
Fontaine, Manon
Galloula, Alexandre
Damotte, Diane
Chatellier, Gilles
Paterlini-Bréchot, Patrizia
Meyer, Guy
Pastre, Jean
Duchatelle, Véronique
Marini, Valéria
Schwering, Karl-Léo
Lazareth, Isabelle
Ghaffari, Parinaz
Stansal, Audrey
Sanson, Hélène
Labrousse, Cécile
Beaussier, Hélène
Nasr, Nesrine Ben
Zins, Marc
Salmeron, Sergio
Messas, Emmanuel
Lajonchère, Jean-Patrick
Emmerich, Joseph
Priollet, Pascal
Trédaniel, Jean http://orcid.org/0000-0003-1369-5668
Funding for this research was provided by:
Institut National Du Cancer (2016-085)
Article History
Received: 11 May 2019
Accepted: 6 September 2019
First Online: 13 September 2019
Ethics approval and consent to participate
: Participants are consecutively included after signed informed consent.The study was registered in the French National Agency for Medicines and Health Products Safety (No N° EUDRACT_ID RCB: 2016-A00657–44) and was approved by the ethics Committee for Persons Protection (Comité de Protection des Personnes Ile de France II, IRB number 1072 and n° initial agreement 2016-08-02, ExternalRef removed identifier NCT02849041).
: Not applicable.
: The authors declare that they have no competing interests.